Fear of cancer recurrence (FCR) is the greatest unmet psychosocial need among breast cancer survivors (BCS). The Oncotype Dx® test predicts the 10-year risk of distant recurrence and benefit of adjuvant chemotherapy among women with early stage hormone receptor-positive breast cancer. Despite the test's clinical utility, psychosocial responses are poorly understood.

中文翻译：

---

探索基因组检测对乳腺癌幸存者癌症复发恐惧的影响

对癌症复发的恐惧 (FCR) 是乳腺癌幸存者 (BCS) 中最大的未满足的心理社会需求。Oncotype Dx® 测试可预测早期激素受体阳性乳腺癌女性的 10 年远处复发风险和辅助化疗的益处。尽管该测试具有临床效用，但人们对社会心理反应知之甚少。